AU6238696A - Cck-4, a receptor tyrosine kinase, and methods for diagnosis and treatment of cck-4 signal transduction disorders - Google Patents
Cck-4, a receptor tyrosine kinase, and methods for diagnosis and treatment of cck-4 signal transduction disordersInfo
- Publication number
- AU6238696A AU6238696A AU62386/96A AU6238696A AU6238696A AU 6238696 A AU6238696 A AU 6238696A AU 62386/96 A AU62386/96 A AU 62386/96A AU 6238696 A AU6238696 A AU 6238696A AU 6238696 A AU6238696 A AU 6238696A
- Authority
- AU
- Australia
- Prior art keywords
- cck
- diagnosis
- treatment
- methods
- tyrosine kinase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45263095A | 1995-05-25 | 1995-05-25 | |
US452630 | 1995-05-25 | ||
PCT/IB1996/000696 WO1996037610A2 (en) | 1995-05-25 | 1996-05-24 | Cck-4, a receptor tyrosine kinase, and methods for diagnosis and treatment of cck-4 signal transduction disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6238696A true AU6238696A (en) | 1996-12-11 |
Family
ID=23797255
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU62386/96A Abandoned AU6238696A (en) | 1995-05-25 | 1996-05-24 | Cck-4, a receptor tyrosine kinase, and methods for diagnosis and treatment of cck-4 signal transduction disorders |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU6238696A (en) |
WO (1) | WO1996037610A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7034132B2 (en) | 2001-06-04 | 2006-04-25 | Anderson David W | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
GB0219776D0 (en) * | 2002-08-24 | 2002-10-02 | Oxford Glycosciences Uk Ltd | A protein involved in carcinoma |
WO2005063987A1 (en) * | 2003-12-19 | 2005-07-14 | Aveo Pharmaceuticals, Inc. | Gp153: methods and compositions for treating cancer |
NZ569236A (en) | 2005-12-08 | 2012-06-29 | Medarex Inc | Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and their use |
EP2380909A1 (en) | 2010-04-26 | 2011-10-26 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | PTK-7 protein involved in breast cancer |
-
1996
- 1996-05-24 AU AU62386/96A patent/AU6238696A/en not_active Abandoned
- 1996-05-24 WO PCT/IB1996/000696 patent/WO1996037610A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1996037610A3 (en) | 1997-01-16 |
WO1996037610A2 (en) | 1996-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL321538A1 (en) | Additional protein of a human interleukin-1 receptor | |
AU697649B2 (en) | Pharmaceutical compositions and methods for modulating signal transduction | |
AU6656796A (en) | Transcorneal drug-release system | |
AU4645596A (en) | Pharmaceutical compositions for prevention and treatment of central nervous system disorders | |
AU5180493A (en) | HER4 human receptor tyrosine kinase | |
AU5482696A (en) | Orthotic apparatus useful for treating pain associated with spinal disorders | |
AU6406996A (en) | Compositions for the treatment and diagnosis of body weight disorders, including obesity | |
AU2396000A (en) | Treatment of hyperproliferative disorders using casein kinase | |
AU2766395A (en) | Human g-protein receptor hgber32 | |
ZA952587B (en) | Human tumor necrosis factor receptor | |
AU5383196A (en) | Pharmaceutical compositions for prevention and treatment of central nervous system disorders | |
AU2384500A (en) | Compounds, methods of screening and methods of treatment for central and peripheral nervous system disorders | |
AU1686997A (en) | Modified vegf antisense oligonucleotides for treatment of skin disorders | |
AU6238696A (en) | Cck-4, a receptor tyrosine kinase, and methods for diagnosis and treatment of cck-4 signal transduction disorders | |
AU6336096A (en) | Non-invasive uterine activity sensor | |
AU6485496A (en) | Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor | |
AU5801596A (en) | Non-invasive testing of video signals | |
AU4785796A (en) | Novel allele of human histamine h2 receptor and methods of detection of h2 receptor variants | |
EP0815133A4 (en) | Human stat4 | |
AU4754496A (en) | Methods for diagnosis and treatment of mdk1 signal transduction disorders | |
AU7059296A (en) | NK-1 receptor antagonists for the treatment of cancer | |
NZ316940A (en) | Carboxylic acid derivatives, their preparation and their use for the treatment of endothelin receptor disorders | |
AU2663495A (en) | Human g-protein receptor hcegh45 | |
AU2233495A (en) | Treatment or diagnosis of abnormal signal transduction disorders | |
AU8019494A (en) | Human endothelin-bombesin receptor |